Press release
July 6, 2026
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Aligos Therapeutics, Inc. (ALGS)
Access Denied You don't have permission to access "http://investor.aligos.com/news-releases/news-release-details/aligos-therapeutics-receives-upfront-payment-25m-usd-exclusive" on this server. Reference #18.3c411002.1785387884.353ec65 https://errors.edgesuite.net/18.3c411002.1785387884.353ec65